CareDx, Inc. reported $458M of revenue over the trailing twelve months, +34% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $458M (to Q2 2026). Net income: $111M, trailing twelve months to Q2 2026. Free cash flow: $41M, trailing twelve months to Q2 2026. Operating margin: 20%, trailing twelve months to Q2 2026.

CDNACareDx, Inc.

Healthcare

$63.68+336% 1Y

$63.68

$14.2852 weeks$69.81

CDNA as reported

CareDx, Inc. reported $458M of revenue over the trailing twelve months, +34% on the year before. 11 reported series are charted on this page, each one as filed.

$458M

Revenue, trailing twelve months · to Q2 2026 · +34% against the twelve months before

Net income: $111M
Net income · +91% year on year · trailing twelve months to Q2 2026
Free cash flow: $41M
Free cash flow · −2944% year on year · trailing twelve months to Q2 2026
Operating margin: 20%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CDNA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$458M	+34%	Q2 2026
Net income	$111M	+91%	Q2 2026
EPS	$2.07	+97%	Q2 2026
Gross margin	66%	n/a	Q2 2020 · 24 quarters behind
Operating margin	20%	n/a	Q2 2026
Net margin	21%	n/a	Q2 2026
ROE	9.8%	n/a	Q2 2026
ROA	7.5%	n/a	Q2 2026
ROIC	−30%	n/a	Q4 2019 · 26 quarters behind
Free cash flow	$41M	−2944%	Q2 2026
P/E	30.8	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.